The Host Antimicrobial Peptide Bac71-35 Binds to Bacterial Ribosomal Proteins and Inhibits Protein Synthesis

•Bac71-35 reaches high concentration after internalization in E. coli cytoplasm•The peptide specifically inhibits bacterial protein synthesis in vitro and in vivo•Bac71-35 binds ribosomes interacting with a precise subset of ribosomal proteins•Bac71-35 exerts its bactericidal activity inhibiting protein synthesis

SummaryAntimicrobial peptides (AMPs) are molecules from innate immunity with high potential as novel anti-infective agents. Most of them inactivate bacteria through pore formation or membrane barrier disruption, but others cross the membrane without damages and act inside the cells, affecting vital processes. However, little is known about their intracellular bacterial targets. Here we report that Bac71-35, a proline-rich AMP belonging to the cathelicidin family, can reach high concentrations (up to 340 μM) inside the E. coli cytoplasm. The peptide specifically and completely inhibits in vitro translation in the micromolar concentration range. Experiments of incorporation of radioactive precursors in macromolecules with E. coli cells confirmed that Bac71-35 affects specifically protein synthesis. Ribosome coprecipitation and crosslinking assays showed that the peptide interacts with ribosomes, binding to a limited subset of ribosomal proteins. Overall, these results indicate that the killing mechanism of Bac71-35 is based on a specific block of protein synthesis.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (313 K)Download as PowerPoint slide